Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

FORM 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT

21st Apr 2021 14:36

 

FORM 8.3

Amendment to sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)Barclays PLC.
Company dealt inWILLIS TOWERS WATSON PLC
Class of relevant security to which theORD
dealings being disclosed relate (Note 2)
Date of dealing16 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,686,965

1.31%

166,384

0.13%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

72,359

0.06%

7,100

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

(4)

TOTAL:

 

 

 

 

1,765,424

1.37%

179,584

0.14%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

1

242.2800 USD
Purchase

1

240.0500 USD
Purchase

2

238.8200 USD
Purchase

7

241.0321 USD
Purchase

8

241.2100 USD
Purchase

8

240.8500 USD
Purchase

8

240.2350 USD
Purchase

19

240.0300 USD
Purchase

25

241.3040 USD
Purchase

31

239.9916 USD
Purchase

55

240.3800 USD
Purchase

82

240.9200 USD
Purchase

100

240.0600 USD
Purchase

108

240.2611 USD
Purchase

116

240.1058 USD
Purchase

174

240.1806 USD
Purchase

177

240.0641 USD
Purchase

200

239.9900 USD
Purchase

212

240.1006 USD
Purchase

300

238.4166 USD
Purchase

314

240.0828 USD
Purchase

336

240.0388 USD
Purchase

796

240.0899 USD
Purchase

839

240.3426 USD
Purchase

1,055

240.1947 USD
Purchase

1,821

239.9873 USD
Purchase

1,859

240.2144 USD
Purchase

4,284

240.0521 USD
Purchase

4,288

240.0780 USD
Purchase

4,599

242.2000 USD
Purchase

6,561

240.0965 USD
Purchase

8,778

241.9157 USD
Purchase

9,502

240.6383 USD
Purchase

12,006

240.0555 USD
Purchase

15,198

239.9650 USD
Purchase

15,526

240.0373 USD
Purchase

18,050

240.4000 USD
Sale

2

238.8200 USD
Sale

2

240.7350 USD
Sale

2

241.1312 USD
Sale

7

239.9800 USD
Sale

18

240.2216 USD
Sale

24

240.4233 USD
Sale

28

240.4053 USD
Sale

29

238.4389 USD
Sale

64

240.1400 USD
Sale

70

240.4952 USD
Sale

76

242.2000 USD
Sale

82

240.9200 USD
Sale

111

240.1031 USD
Sale

122

240.0338 USD
Sale

171

240.0118 USD
Sale

200

239.9900 USD
Sale

200

239.9275 USD
Sale

200

241.3225 USD
Sale

265

239.7398 USD
Sale

300

238.4166 USD
Sale

301

240.0432 USD
Sale

340

239.9274 USD
Sale

399

241.2492 USD
Sale

729

239.9280 USD
Sale

771

240.3502 USD
Sale

899

240.1488 USD
Sale

1,006

240.4874 USD
Sale

1,123

240.0011 USD
Sale

1,501

240.2718 USD
Sale

2,729

239.9767 USD
Sale

3,024

240.2278 USD
Sale

3,430

240.0504 USD
Sale

3,451

240.0083 USD
Sale

4,252

240.1241 USD
Sale

6,537

239.6061 USD
Sale

7,163

240.6904 USD
Sale

8,444

240.0655 USD
Sale

8,786

241.9151 USD
Sale

8,835

240.2349 USD
Sale

10,249

240.4000 USD
Sale

12,351

240.4278 USD
Sale

18,866

240.0365 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?YES
Date of disclosure:21 Apr 2021
Contact name:Large Holdings Regulatory Operations
Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product nameWritten orNumber ofExerciseTypeExpiry
purchasedrelevant securitiespricedate
to which the option

 

or derivative

 

 

 

 

relates

 

 

 

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210421005671/en/

Copyright Business Wire 2021


Related Shares:

Barclays
FTSE 100 Latest
Value8,837.91
Change26.87